Isolation	O
of	O
a	O
candidate	O
repressor/activator	O
,	O
NF-E1	B-protein
(	O
YY-1	B-protein
,	O
delta	B-protein
)	O
,	O
that	O
binds	O
to	O
the	O
immunoglobulin	B-DNA
kappa	I-DNA
3	I-DNA
'	I-DNA
enhancer	I-DNA
and	O
the	O
immunoglobulin	B-DNA
heavy-chain	I-DNA
mu	I-DNA
E1	I-DNA
site	I-DNA
.	O

We	O
have	O
determined	O
that	O
the	O
developmental	O
control	O
of	O
immunoglobulin	B-DNA
kappa	I-DNA
3	I-DNA
'	I-DNA
enhancer	I-DNA
(	O
kappa	B-DNA
E3	I-DNA
'	I-DNA
)	O
activity	O
is	O
the	O
result	O
of	O
the	O
combined	O
influence	O
of	O
positive-	B-DNA
and	I-DNA
negative-acting	I-DNA
elements	I-DNA
.	O

We	O
show	O
that	O
a	O
central	O
core	O
in	O
the	O
kappa	B-DNA
E3	I-DNA
'	I-DNA
enhancer	I-DNA
is	O
active	O
at	O
the	O
pre-B-cell	O
stage	O
but	O
is	O
repressed	O
by	O
flanking	B-DNA
negative-acting	I-DNA
elements	I-DNA
.	O

The	O
negative-acting	B-DNA
sequences	I-DNA
repress	O
enhancer	O
activity	O
in	O
a	O
position-	O
and	O
orientation-independent	O
manner	O
at	O
the	O
pre-B-cell	O
stage	O
.	O

We	O
have	O
isolated	O
a	O
human	B-DNA
cDNA	I-DNA
clone	I-DNA
encoding	O
a	O
zinc	B-protein
finger	I-protein
protein	I-protein
(	O
NF-E1	B-protein
)	O
that	O
binds	O
to	O
the	O
negative-acting	B-DNA
segment	I-DNA
of	O
the	O
kappa	B-DNA
E3	I-DNA
'	I-DNA
enhancer	I-DNA
.	O

This	O
protein	O
also	O
binds	O
to	O
the	O
immunoglobulin	B-DNA
heavy-chain	I-DNA
enhancer	I-DNA
mu	I-DNA
E1	I-DNA
site	I-DNA
.	O

NF-E1	B-protein
is	O
encoded	O
by	O
the	O
same	O
gene	O
as	O
the	O
YY-1	B-protein
protein	I-protein
,	O
which	O
binds	O
to	O
the	O
adeno-associated	B-DNA
virus	I-DNA
P5	I-DNA
promoter	I-DNA
.	O

NF-E1	B-protein
is	O
also	O
the	O
human	B-protein
homologue	I-protein
of	O
the	O
mouse	B-DNA
delta	I-DNA
protein	I-DNA
,	O
which	O
binds	O
to	O
ribosomal	B-DNA
protein	I-DNA
gene	I-DNA
promoters	I-DNA
.	O

The	O
predicted	O
amino	O
acid	O
sequence	O
of	O
this	O
protein	O
contains	O
features	O
characteristic	O
of	O
transcriptional	B-protein
activators	I-protein
as	O
well	O
as	O
transcriptional	B-protein
repressors	I-protein
.	O

Cotransfection	O
studies	O
with	O
this	O
cDNA	B-DNA
indicate	O
that	O
it	O
can	O
repress	O
basal	B-DNA
promoter	I-DNA
activity	O
.	O

The	O
apparent	O
dual	O
function	O
of	O
this	O
protein	O
is	O
discussed	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

88	NULL
,	NULL
pp	NULL
.	NULL

9804-9808	NULL
,	NULL
November	NULL
1991	NULL
Biochemistry	NULL
Isolation	NULL
of	NULL
a	NULL
candidate	NULL
repressor	NULL
/activator	NULL
,	NULL
NF-E1	NULL
(	NULL
YY-1	NULL
,	NULL
8	NULL
)	NULL
,	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
immunoglobulin	NULL
x	NULL
3	NULL
'	NULL
enhancer	NULL
and	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
uE1	NULL
site	NULL
(	NULL
transcription	NULL
/developmental	NULL
control	NULL
/negative	NULL
regulation	NULL
)	NULL
KvyounGsooKk	NULL
PARK	NULL
AnD	NULL
MICHAEL	NULL
L.	NULL
AtTcHISON	NULL
Department	NULL
of	NULL
Animal	NULL
Biology	NULL
,	NULL
Biomedical	NULL
Graduate	NULL
Studies	NULL
,	NULL
Molecular	NULL
Biology	NULL
Program	NULL
,	NULL
University	NULL
of	NULL
Pennsylvania	NULL
,	NULL
School	NULL
of	NULL
Veterinary	NULL
Medicine	NULL
,	NULL
3800	NULL
Spruce	NULL
Street	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
19104	NULL
Communicated	NULL
by	NULL
Robert	NULL
P.	NULL
Perry	NULL
,	NULL
August	NULL
7	NULL
,	NULL
1991	NULL
ABSTRACT	NULL
We	NULL
have	NULL
determined	NULL
that	NULL
the	NULL
developmental	NULL
control	NULL
of	NULL
immunoglobulin	NULL
x	NULL
3	NULL
'	NULL
enhancer	NULL
(	NULL
«	NULL
E3	NULL
'	NULL
)	NULL
activity	NULL
is	NULL
the	NULL
result	NULL
of	NULL
the	NULL
combined	NULL
influence	NULL
of	NULL
positive-	NULL
and	NULL
negative-acting	NULL
elements	NULL
.	NULL

We	NULL
show	NULL
that	NULL
a	NULL
central	NULL
core	NULL
in	NULL
the	NULL
xE3	NULL
'	NULL
enhancer	NULL
is	NULL
active	NULL
at	NULL
the	NULL
pre-B-cell	NULL
stage	NULL
but	NULL
is	NULL
repressed	NULL
by	NULL
flanking	NULL
negative-acting	NULL
elements	NULL
.	NULL

The	NULL
negative-acting	NULL
sequences	NULL
repress	NULL
enhancer	NULL
activity	NULL
in	NULL
a	NULL
position-	NULL
and	NULL
orientation-independent	NULL
manner	NULL
at	NULL
the	NULL
pre-B-cell	NULL
stage	NULL
.	NULL

We	NULL
have	NULL
isolated	NULL
a	NULL
human	NULL
cDNA	NULL
clone	NULL
encoding	NULL
a	NULL
zinc	NULL
finger	NULL
protein	NULL
(	NULL
NF-E1	NULL
)	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
negative-acting	NULL
segment	NULL
of	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
enhancer	NULL
.	NULL

This	NULL
protein	NULL
also	NULL
binds	NULL
to	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
enhancer	NULL
E1	NULL
site	NULL
.	NULL

NF-E1	NULL
is	NULL
encoded	NULL
by	NULL
the	NULL
same	NULL
gene	NULL
as	NULL
the	NULL
YY-1	NULL
protein	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
adeno-associated	NULL
virus	NULL
PS	NULL
promoter	NULL
.	NULL

NF-E1	NULL
is	NULL
also	NULL
the	NULL
human	NULL
homologue	NULL
of	NULL
the	NULL
mouse	NULL
8	NULL
protein	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
ribosomal	NULL
protein	NULL
gene	NULL
promoters	NULL
.	NULL

The	NULL
predicted	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
this	NULL
protein	NULL
contains	NULL
features	NULL
characteristic	NULL
of	NULL
transcriptional	NULL
activators	NULL
as	NULL
well	NULL
as	NULL
transcriptional	NULL
repressors	NULL
.	NULL

Cotransfection	NULL
studies	NULL
with	NULL
this	NULL
cDNA	NULL
indicate	NULL
that	NULL
it	NULL
can	NULL
repress	NULL
basal	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
apparent	NULL
dual	NULL
function	NULL
of	NULL
this	NULL
protein	NULL
is	NULL
discussed	NULL
.	NULL

Immunoglobulin	NULL
x	NULL
gene	NULL
expression	NULL
is	NULL
tissue	NULL
specific	NULL
and	NULL
is	NULL
developmentally	NULL
regulated	NULL
during	NULL
B-cell	NULL
development	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL

Immunoglobulin	NULL
x	NULL
transcription	NULL
is	NULL
governed	NULL
by	NULL
two	NULL
enhancers	NULL
:	NULL
one	NULL
(	NULL
Ex	NULL
)	NULL
lies	NULL
within	NULL
the	NULL
intron	NULL
separating	NULL
the	NULL
joining	NULL
and	NULL
constant	NULL
regions	NULL
,	NULL
and	NULL
the	NULL
other	NULL
(	NULL
«	NULL
E3	NULL
'	NULL
)	NULL
lies	NULL
downstream	NULL
of	NULL
the	NULL
constant	NULL
region	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

Both	NULL
enhancers	NULL
are	NULL
tissue	NULL
specific	NULL
and	NULL
both	NULL
are	NULL
developmentally	NULL
controlled	NULL
(	NULL
3-6	NULL
)	NULL
.	NULL

That	NULL
is	NULL
,	NULL
both	NULL
enhancers	NULL
are	NULL
normally	NULL
silent	NULL
at	NULL
the	NULL
pre-B-cell	NULL
stage	NULL
but	NULL
are	NULL
active	NULL
at	NULL
the	NULL
B-cell	NULL
and	NULL
plasma	NULL
cell	NULL
stages	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
intron	NULL
enhancer	NULL
is	NULL
controlled	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
active	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
7-10	NULL
)	NULL
.	NULL

The	NULL
3	NULL
'	NULL
enhancer	NULL
,	NULL
however	NULL
,	NULL
does	NULL
not	NULL
require	NULL
NF-	NULL
«	NULL
B	NULL
for	NULL
its	NULL
activity	NULL
(	NULL
6	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
mechanism	NULL
of	NULL
its	NULL
silence	NULL
at	NULL
the	NULL
pre-B-cell	NULL
stage	NULL
is	NULL
unclear	NULL
.	NULL

Silence	NULL
of	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
enhancer	NULL
at	NULL
the	NULL
pre-B-cell	NULL
stage	NULL
could	NULL
be	NULL
due	NULL
to	NULL
either	NULL
the	NULL
lack	NULL
of	NULL
positive-acting	NULL
factors	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
negative-acting	NULL
factors	NULL
,	NULL
or	NULL
both	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
functionally	NULL
characterized	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
enhancer	NULL
and	NULL
identified	NULL
a	NULL
132-base-pair	NULL
(	NULL
bp	NULL
)	NULL
core	NULL
that	NULL
retains	NULL
75	NULL
%	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
intact	NULL
l-kilobase	NULL
(	NULL
kb	NULL
)	NULL
enhancer	NULL
in	NULL
plasmacytoma	NULL
cells	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Sequences	NULL
flanking	NULL
this	NULL
132-bp	NULL
core	NULL
contribute	NULL
very	NULL
little	NULL
to	NULL
enhancer	NULL
activity	NULL
at	NULL
this	NULL
stage	NULL
of	NULL
B-cell	NULL
development	NULL
.	NULL

It	NULL
is	NULL
unknown	NULL
whether	NULL
sequences	NULL
within	NULL
this	NULL
core	NULL
are	NULL
capable	NULL
of	NULL
being	NULL
active	NULL
at	NULL
the	NULL
pre-B-cell	NULL
stage	NULL
of	NULL
development	NULL
or	NULL
whether	NULL
there	NULL
are	NULL
negative-acting	NULL
elements	NULL
in	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
enhancer	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
enhancer	NULL
132-bp	NULL
core	NULL
is	NULL
indeed	NULL
active	NULL
at	NULL
the	NULL
pre-B-cell	NULL
stage	NULL
.	NULL

Downstream	NULL
of	NULL
the	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

$	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

9804	NULL
132-bp	NULL
core	NULL
we	NULL
have	NULL
identified	NULL
a	NULL
segment	NULL
that	NULL
represses	NULL
activity	NULL
of	NULL
the	NULL
enhancer	NULL
at	NULL
the	NULL
pre-B-cell	NULL
stage	NULL
.	NULL

We	NULL
have	NULL
isolated	NULL
a	NULL
human	NULL
cDNA	NULL
clone	NULL
encoding	NULL
a	NULL
zinc	NULL
finger	NULL
protein	NULL
(	NULL
NF-E1	NULL
)	NULL
that	NULL
binds	NULL
to	NULL
a	NULL
DNA	NULL
sequence	NULL
within	NULL
the	NULL
negative-acting	NULL
segment	NULL
.	NULL

This	NULL
factor	NULL
also	NULL
binds	NULL
to	NULL
the	NULL
uE1	NULL
site	NULL
of	NULL
the	NULL
heavy-chain	NULL
enhancer	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
NF-E1	NULL
reveals	NULL
features	NULL
in	NULL
common	NULL
with	NULL
both	NULL
transcriptional	NULL
activators	NULL
as	NULL
well	NULL
as	NULL
transcriptional	NULL
repressors	NULL
.	NULL

*	NULL
Cotransfection	NULL
with	NULL
this	NULL
cDNA	NULL
results	NULL
in	NULL
repression	NULL
of	NULL
basal	NULL
promoter	NULL
activity	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmid	NULL
Constructions	NULL
.	NULL

Construct	NULL
A	NULL
contains	NULL
a	NULL
Bei	NULL
II/Xba	NULL
I	NULL
DNA	NULL
fragment	NULL
(	NULL
residues	NULL
80-808	NULL
)	NULL
of	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
enhancer	NULL
upstream	NULL
of	NULL
the	NULL
herpesvirus	NULL
thymidine	NULL
kinase	NULL
(	NULL
TK	NULL
)	NULL
promoter	NULL
and	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
sequences	NULL
.	NULL

Plasmids	NULL
B-G	NULL
were	NULL
prepared	NULL
either	NULL
by	NULL
BAL-31	NULL
deletion	NULL
or	NULL
by	NULL
PCR	NULL
amplification	NULL
of	NULL
appropriate	NULL
portions	NULL
of	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
enhancer	NULL
.	NULL

Plasmid	NULL
J	NULL
was	NULL
prepared	NULL
by	NULL
a	NULL
PCR-based	NULL
linker	NULL
scan	NULL
procedure	NULL
(	NULL
12	NULL
)	NULL
such	NULL
that	NULL
the	NULL
NF-E1	NULL
sequence	NULL
was	NULL
changed	NULL
from	NULL
CCTCCATC	NULL
to	NULL
AGAATTCA	NULL
.	NULL

Plasmids	NULL
H	NULL
and	NULL
I	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
GAL4-E1	NULL
and	NULL
GAL4-rEl	NULL
fusion	NULL
constructs	NULL
contain	NULL
the	NULL
insert	NULL
from	NULL
clone	NULL
324	NULL
in	NULL
either	NULL
orientation	NULL
at	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
plasmid	NULL
pSG424	NULL
(	NULL
13	NULL
)	NULL
.	NULL

SV-E1	NULL
and	NULL
SV-rE1	NULL
contain	NULL
the	NULL
clone	NULL
131	NULL
cDNA	NULL
in	NULL
either	NULL
orientation	NULL
driven	NULL
by	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
promoter	NULL
and	NULL
enhancer	NULL
.	NULL

Cell	NULL
Culture	NULL
,	NULL
Transfections	NULL
,	NULL
and	NULL
CAT	NULL
Assays	NULL
.	NULL

1-8	NULL
cells	NULL
were	NULL
grown	NULL
and	NULL
transfected	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
procedure	NULL
as	NULL
described	NULL
(	NULL
6	NULL
)	NULL
.	NULL

3T3	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
horse	NULL
serum	NULL
(	NULL
GIBCO	NULL
)	NULL
and	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
coprecipitation	NULL
method	NULL
(	NULL
14	NULL
)	NULL
.	NULL

3T3	NULL
transfections	NULL
contained	NULL
4	NULL
ug	NULL
of	NULL
reporter	NULL
plasmid	NULL
,	NULL
15	NULL
ug	NULL
of	NULL
effector	NULL
plasmid	NULL
,	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
the	NULL
B-galactosidase	NULL
expression	NULL
plasmid	NULL
pCH110	NULL
(	NULL
15	NULL
)	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Gorman	NULL
et	NULL
al	NULL
.	NULL

(	NULL
16	NULL
)	NULL
.	NULL

Gel	NULL
Mobility	NULL
Shift	NULL
and	NULL
Methylation	NULL
Interference	NULL
Assays	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Singh	NULL
et	NULL
al	NULL
.	NULL

(	NULL
17	NULL
)	NULL
.	NULL

For	NULL
methylation	NULL
interference	NULL
assays	NULL
,	NULL
a	NULL
75-bp	NULL
Hae	NULL
III/BstNl	NULL
fragment	NULL
containing	NULL
the	NULL
NF-E1	NULL
binding	NULL
site	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
HinclI	NULL
site	NULL
of	NULL
pUCI18	NULL
.	NULL

This	NULL
plasmid	NULL
was	NULL
cut	NULL
with	NULL
BamHI	NULL
,	NULL
dephosphory-lated	NULL
with	NULL
calf	NULL
intestine	NULL
phosphatase	NULL
,	NULL
and	NULL
then	NULL
labeled	NULL
with	NULL
[	NULL
y-	NULL
>	NULL
P	NULL
]	NULL
JATP	NULL
by	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

Partial	NULL
methylation	NULL
,	NULL
binding	NULL
reactions	NULL
with	NULL
Ag8	NULL
nuclear	NULL
extract	NULL
,	NULL
and	NULL
electropho-resis	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Screening	NULL
of	NULL
the	NULL
cDNA	NULL
Expression	NULL
Library	NULL
.	NULL

A	NULL
human	NULL
B-cell-derived	NULL
Agtll	NULL
cDNA	NULL
library	NULL
(	NULL
human	NULL
B-cell	NULL
leukemia	NULL
RPM	NULL
Abbreviations	NULL
:	NULL
TK	NULL
,	NULL
thymidine	NULL
kinase	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
ace-tyltransferase	NULL
.	NULL

*The	NULL
sequence	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
has	NULL
been	NULL
deposited	NULL
in	NULL
the	NULL
GenBank	NULL
data	NULL
base	NULL
(	NULL
accession	NULL
no	NULL
.	NULL

M76541	NULL
)	NULL
.	NULL

Biochemistry	NULL
:	NULL
Park	NULL
and	NULL
Atchison	NULL
4265	NULL
;	NULL
Clontech	NULL
)	NULL
was	NULL
screened	NULL
with	NULL
a	NULL
labeled	NULL
multimerized	NULL
DNA	NULL
binding	NULL
site	NULL
oligonucleotide	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Vinson	NULL
et	NULL
al	NULL
.	NULL

(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
oligonucleotide	NULL
used	NULL
for	NULL
screening	NULL
is	NULL
GATCCTACCCCACCTCCATCTTGTTTGATA	NULL
GATGGGGTGGAGGTAGAACAAACTATCTAG	NULL
DNA	NULL
Sequence	NULL
Analysis	NULL
,	NULL
DNA	NULL
sequences	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
dideoxynucleotide	NULL
chain-termination	NULL
method	NULL
on	NULL
dou-ble-stranded	NULL
DNA	NULL
templates	NULL
using	NULL
the	NULL
United	NULL
States	NULL
Biochemical	NULL
sequencing	NULL
kit	NULL
.	NULL

In	NULL
Vitro	NULL
Transcription	NULL
and	NULL
Translation	NULL
.	NULL

Clone	NULL
131	NULL
in	NULL
pBlue-script	NULL
was	NULL
linearized	NULL
with	NULL
Xba	NULL
I	NULL
and	NULL
then	NULL
transcribed	NULL
with	NULL
T7	NULL
polymerase	NULL
using	NULL
an	NULL
mRNA	NULL
capping	NULL
kit	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
specifications	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

The	NULL
capped	NULL
mRNA	NULL
was	NULL
subjected	NULL
to	NULL
in	NULL
vitro	NULL
translation	NULL
with	NULL
a	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

RESULTS	NULL
The	NULL
«	NULL
E3	NULL
'	NULL
Core	NULL
Is	NULL
Active	NULL
in	NULL
pre-B	NULL
Cells	NULL
and	NULL
Is	NULL
Flanked	NULL
by	NULL
Negative-Acting	NULL
Elements	NULL
,	NULL
.	NULL

We	NULL
set	NULL
out	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
132-bp	NULL
«	NULL
E3	NULL
'	NULL
core	NULL
is	NULL
active	NULL
at	NULL
the	NULL
pre-B-cell	NULL
stage	NULL
.	NULL

The	NULL
132-bp	NULL
core	NULL
segment	NULL
was	NULL
linked	NULL
to	NULL
the	NULL
herpesvirus	NULL
TK	NULL
promoter	NULL
driving	NULL
expression	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
this	NULL
construct	NULL
was	NULL
compared	NULL
to	NULL
that	NULL
of	NULL
the	NULL
intact	NULL
enhancer	NULL
contained	NULL
on	NULL
a	NULL
728-bp	NULL
DNA	NULL
fragment	NULL
(	NULL
containing	NULL
311	NULL
bp	NULL
5	NULL
'	NULL
and	NULL
285	NULL
bp	NULL
3	NULL
'	NULL
of	NULL
the	NULL
core	NULL
)	NULL
after	NULL
transfection	NULL
into	NULL
1-8	NULL
pre-B	NULL
cells	NULL
.	NULL

The	NULL
132-bp	NULL
core	NULL
segment	NULL
was	NULL
~10-fold	NULL
more	NULL
active	NULL
than	NULL
the	NULL
728-bp	NULL
enhancer	NULL
fragment	NULL
in	NULL
pre-B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
compare	NULL
constructs	NULL
A	NULL
and	NULL
I	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
the	NULL
presence	NULL
of	NULL
negative	NULL
regulatory	NULL
elements	NULL
within	NULL
the	NULL
728-bp	NULL
enhancer	NULL
fragment	NULL
that	NULL
are	NULL
deleted	NULL
in	NULL
the	NULL
132-bp	NULL
fragment	NULL
.	NULL

To	NULL
search	NULL
for	NULL
these	NULL
negative	NULL
elements	NULL
,	NULL
various	NULL
deletion	NULL
mutants	NULL
were	NULL
prepared	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
sequences	NULL
between	NULL
positions	NULL
808	NULL
and	NULL
658	NULL
did	NULL
not	NULL
increase	NULL
activity	NULL
of	NULL
the	NULL
enhancer	NULL
A	NULL
Relative	NULL
Activity	NULL
A	NULL
80-808	NULL
[	NULL
)	NULL
1	NULL
B	NULL
80.682	NULL
[	NULL
OO	NULL
___	NULL
OOO	NULL
COO	NULL
]	NULL
0.9	NULL
+/-	NULL
0.2	NULL
c	NULL
sosss	NULL
[	NULL
___	NULL
OOO	NULL
]	NULL
0.8	NULL
+/-	NULL
0.2	NULL
p	NULL
sos	NULL
[	NULL
COCO	NULL
J	NULL
1.7	NULL
+/-	NULL
0.3	NULL
E	NULL
so581	NULL
[	NULL
LOO	NULL
OO	NULL
O22	NULL
]	NULL
1.8	NULL
+/-	NULL
0.2	NULL
F	NULL
so-sss	NULL
[	NULL
LCCC	NULL
]	NULL
4.2	NULL
+/-	NULL
0.5	NULL
a	NULL
so53e	NULL
[	NULL
COO	NULL
O	NULL
OJ	NULL
5.3	NULL
+/-	NULL
1.6	NULL
n	NULL
so-s23	NULL
[	NULL
LLCO	NULL
OOO	NULL
O	NULL
000	NULL
73	NULL
w	NULL
2	NULL
1	NULL
391-523	NULL
CI	NULL
]	NULL
10.7	NULL
+/	NULL
2	NULL
J	NULL
LSE1	NULL
[	NULL
T__	NULL
)	NULL
1.3	NULL
+/	NULL
0.08	NULL
B	NULL
--	NULL
-	NULL
>	NULL
15	NULL
%	NULL
w=	NULL
-im	NULL
11	NULL
%	NULL
t-	NULL
.	NULL

2	NULL
29	NULL
%	NULL
471	NULL
%	NULL
%	NULL
%	NULL
”	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Identification	NULL
of	NULL
negative-acting	NULL
segments	NULL
in	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
enhancer	NULL
.	NULL

(	NULL
A	NULL
)	NULL
DNA	NULL
sequences	NULL
present	NULL
in	NULL
each	NULL
construct	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
and	NULL
are	NULL
represented	NULL
by	NULL
open	NULL
boxes	NULL
.	NULL

The	NULL
relative	NULL
activity	NULL
of	NULL
each	NULL
construct	NULL
in	NULL
1-8	NULL
pre-B	NULL
cells	NULL
is	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

Standard	NULL
deviations	NULL
were	NULL
calculated	NULL
from	NULL
three	NULL
to	NULL
five	NULL
transfection	NULL
experi-ments	NULL
.	NULL

In	NULL
construct	NULL
J	NULL
,	NULL
xx	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
a	NULL
linker	NULL
scan	NULL
mutation	NULL
in	NULL
the	NULL
NF-E1	NULL
binding	NULL
site	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Position	NULL
and	NULL
orientation	NULL
of	NULL
sequences	NULL
523-808	NULL
inserted	NULL
into	NULL
construct	NULL
H	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

CAT	NULL
activities	NULL
relative	NULL
to	NULL
construct	NULL
H	NULL
are	NULL
shown	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
9805	NULL
above	NULL
that	NULL
of	NULL
the	NULL
intact	NULL
enhancer	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
compare	NULL
constructs	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
)	NULL
.	NULL

However	NULL
,	NULL
progressive	NULL
deletions	NULL
to	NULL
positions	NULL
615	NULL
,	NULL
558	NULL
,	NULL
536	NULL
,	NULL
and	NULL
523	NULL
(	NULL
constructs	NULL
D	NULL
,	NULL
F	NULL
,	NULL
G	NULL
,	NULL
and	NULL
H	NULL
,	NULL
respectively	NULL
)	NULL
resulted	NULL
in	NULL
stepwise	NULL
increases	NULL
in	NULL
CAT	NULL
activity	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
the	NULL
pre-B-cell	NULL
line	NULL
3-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
the	NULL
existence	NULL
of	NULL
multiple	NULL
negative	NULL
control	NULL
elements	NULL
that	NULL
flank	NULL
the	NULL
3	NULL
'	NULL
side	NULL
of	NULL
the	NULL
132-bp	NULL
core	NULL
of	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
enhancer	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
the	NULL
increased	NULL
enhancer	NULL
activity	NULL
was	NULL
not	NULL
due	NULL
to	NULL
position	NULL
effects	NULL
caused	NULL
by	NULL
the	NULL
various	NULL
deletions	NULL
and	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
negative-acting	NULL
segment	NULL
was	NULL
position	NULL
or	NULL
orientation	NULL
independent	NULL
,	NULL
constructs	NULL
K-N	NULL
were	NULL
prepared	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Construct	NULL
H	NULL
was	NULL
modified	NULL
to	NULL
contain	NULL
sequences	NULL
523-808	NULL
on	NULL
either	NULL
the	NULL
3	NULL
'	NULL
side	NULL
(	NULL
K	NULL
and	NULL
L	NULL
)	NULL
or	NULL
the	NULL
5	NULL
'	NULL
side	NULL
(	NULL
M	NULL
and	NULL
N	NULL
)	NULL
of	NULL
the	NULL
enhancer	NULL
.	NULL

All	NULL
four	NULL
constructs	NULL
repressed	NULL
enhancer	NULL
activity	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
negative-acting	NULL
sequences	NULL
are	NULL
position	NULL
and	NULL
orientation	NULL
independent	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Repression	NULL
ranged	NULL
from	NULL
9-	NULL
to	NULL
3.4-fold	NULL
(	NULL
11-29	NULL
%	NULL
of	NULL
construct	NULL
H	NULL
)	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
Nuclear	NULL
Factor	NULL
That	NULL
Binds	NULL
to	NULL
the	NULL
Negative-Acting	NULL
Region	NULL
of	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
Enhancer	NULL
.	NULL

To	NULL
identify	NULL
nuclear	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
negative-acting	NULL
region	NULL
of	NULL
the	NULL
«	NULL
kE3	NULL
'	NULL
enhancer	NULL
DNA	NULL
fragments	NULL
were	NULL
used	NULL
as	NULL
probes	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

A	NULL
75-bp	NULL
Hae	NULL
III/BsfNI	NULL
DNA	NULL
fragment	NULL
(	NULL
residues	NULL
582-657	NULL
)	NULL
yielded	NULL
a	NULL
single	NULL
bound	NULL
complex	NULL
with	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
cell	NULL
lines	NULL
representative	NULL
of	NULL
the	NULL
pre-B-cell	NULL
,	NULL
B-cell	NULL
,	NULL
and	NULL
plasma	NULL
cell	NULL
stages	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Unlabeled	NULL
DNA	NULL
fragments	NULL
from	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
and	NULL
the	NULL
heavy-chain	NULL
enhancers	NULL
abolished	NULL
protein-DNA	NULL
interaction	NULL
,	NULL
but	NULL
a	NULL
DNA	NULL
fragment	NULL
from	NULL
the	NULL
«	NULL
intron	NULL
enhancer	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
containing	NULL
known	NULL
immunoglobulin	NULL
enhancer	NULL
motifs	NULL
were	NULL
also	NULL
used	NULL
as	NULL
competitors	NULL
.	NULL

An	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
uE1	NULL
binding	NULL
site	NULL
abolished	NULL
the	NULL
DNA-nuclear	NULL
factor	NULL
interaction	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
Upper	NULL
)	NULL
,	NULL
but	NULL
not	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
wE2	NULL
,	NULL
uE3	NULL
,	NULL
uE4	NULL
,	NULL
uE5	NULL
,	NULL
NF-xB	NULL
,	NULL
or	NULL
octamer	NULL
binding	NULL
sites	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
nuclear	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
probe	NULL
appears	NULL
to	NULL
be	NULL
identical	NULL
to	NULL
the	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
4E1	NULL
site	NULL
.	NULL

We	NULL
therefore	NULL
named	NULL
this	NULL
nuclear	NULL
factor	NULL
NF-E1l	NULL
.	NULL

Dimethyl	NULL
sulfate	NULL
methylation	NULL
interference	NULL
assays	NULL
indicated	NULL
that	NULL
methylation	NULL
of	NULL
G	NULL
residues	NULL
623	NULL
,	NULL
624	NULL
,	NULL
626	NULL
,	NULL
627	NULL
,	NULL
and	NULL
630	NULL
on	NULL
the	NULL
bottom	NULL
DNA	NULL
strand	NULL
of	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
enhancer	NULL
interfered	NULL
with	NULL
NF-E1-DNA	NULL
interaction	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
Left	NULL
)	NULL
.	NULL

These	NULL
residues	NULL
in	NULL
the	NULL
«	NULL
kE3	NULL
'	NULL
enhancer	NULL
overlap	NULL
with	NULL
a	NULL
region	NULL
of	NULL
8	NULL
bp	NULL
of	NULL
identity	NULL
with	NULL
the	NULL
heavy-chain	NULL
uE1	NULL
site	NULL
and	NULL
closely	NULL
correspond	NULL
to	NULL
sites	NULL
identified	NULL
by	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
uEl	NULL
dimethyl	NULL
sulfate	NULL
footprinting	NULL
(	NULL
refs	NULL
.	NULL

20	NULL
and	NULL
21	NULL
;	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Isolation	NULL
and	NULL
Characterization	NULL
of	NULL
cDNA	NULL
Clones	NULL
Encoding	NULL
NF-E1	NULL
.	NULL

A	NULL
human	NULL
B-cell	NULL
cDNA	NULL
library	NULL
in	NULL
Agt11	NULL
was	NULL
screened	NULL
with	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
NF-E1	NULL
binding	NULL
sequence	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Vinson	NULL
et	NULL
al	NULL
.	NULL

(	NULL
19	NULL
)	NULL
.	NULL

Of	NULL
250,000	NULL
phage	NULL
plaques	NULL
screened	NULL
,	NULL
we	NULL
obtained	NULL
3	NULL
positive	NULL
clones	NULL
designated	NULL
131	NULL
,	NULL
324	NULL
,	NULL
and	NULL
1021	NULL
.	NULL

The	NULL
largest	NULL
cDNA	NULL
clone	NULL
(	NULL
clone	NULL
324	NULL
)	NULL
was	NULL
sequenced	NULL
in	NULL
its	NULL
entirety	NULL
and	NULL
contains	NULL
2084	NULL
bp	NULL
.	NULL

Clone	NULL
131	NULL
,	NULL
although	NULL
smaller	NULL
than	NULL
clone	NULL
324	NULL
,	NULL
extended	NULL
the	NULL
sequence	NULL
an	NULL
additional	NULL
92	NULL
bp	NULL
in	NULL
the	NULL
5	NULL
'	NULL
direction	NULL
.	NULL

The	NULL
composite	NULL
NF-E1	NULL
sequence	NULL
spans	NULL
2176	NULL
bp	NULL
and	NULL
,	NULL
beginning	NULL
with	NULL
the	NULL
first	NULL
ATG	NULL
triplet	NULL
at	NULL
position	NULL
75	NULL
,	NULL
encodes	NULL
an	NULL
open	NULL
reading	NULL
frame	NULL
of	NULL
414	NULL
amino	NULL
acids	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
first	NULL
methionine	NULL
codon	NULL
conforms	NULL
well	NULL
to	NULL
the	NULL
Kozak	NULL
(	NULL
22	NULL
)	NULL
consensus	NULL
sequence	NULL
.	NULL

The	NULL
termination	NULL
codon	NULL
is	NULL
followed	NULL
by	NULL
860	NULL
bp	NULL
of	NULL
3	NULL
'	NULL
untranslated	NULL
sequence	NULL
.	NULL

A	NULL
polyadenylylation	NULL
signal	NULL
lies	NULL
4	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
cDNA	NULL
sequence	NULL
.	NULL

A	NULL
second	NULL
potential	NULL
polyadenylylation	NULL
signal	NULL
lies	NULL
58	NULL
bp	NULL
downstream	NULL
of	NULL
the	NULL
trans-lational	NULL
termination	NULL
codon	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
predicted	NULL
amino	NULL
acid	NULL
sequence	NULL
revealed	NULL
a	NULL
rather	NULL
unusual	NULL
structure	NULL
.	NULL

First	NULL
,	NULL
in	NULL
the	NULL
C-terminal	NULL
portion	NULL
are	NULL
four	NULL
zinc	NULL
fingers	NULL
of	NULL
the	NULL
Cis-Cis-His-His	NULL
type	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
N-terminal	NULL
portion	NULL
of	NULL
the	NULL
protein	NULL
is	NULL
highly	NULL
acidic	NULL
with	NULL
21	NULL
of	NULL
the	NULL
first	NULL
53	NULL
(	NULL
40	NULL
%	NULL
)	NULL
amino	NULL
acids	NULL
being	NULL
acidic	NULL
.	NULL

This	NULL
region	NULL
9806	NULL
Biochemistry	NULL
:	NULL
Park	NULL
and	NULL
Atchison	NULL
A	NULL
&	NULL
m	NULL
Competitor	NULL
o	NULL
44	NULL
m	NULL
1-¥	NULL
:	NULL
eet	NULL
(	NULL
eloinlelol	NULL
segss	NULL
O	NULL
)	NULL
&	NULL
to	NULL
m	NULL
A	NULL
ag	NULL
xE3	NULL
'	NULL
Enhancer	NULL
NF-E1	NULL
site	NULL
brs	NULL
Ccacet	NULL
ccatecr	NULL
a	NULL
GGTGGAGGTAGAAC	NULL
00	NULL
00	NULL
0	NULL
h	NULL
igh	NULL
Enhancer	NULL
1E1	NULL
site	NULL
00	NULL
Mt	NULL
Gat	NULL
c	NULL
Géccatcre	NULL
ct	NULL
agccgetagaac	NULL
La	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

NF-E1l	NULL
also	NULL
binds	NULL
to	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
E1	NULL
site	NULL
.	NULL

(	NULL
Upper	NULL
Right	NULL
)	NULL
The	NULL
Hae	NULL
III/BstNI	NULL
DNA	NULL
probe	NULL
was	NULL
assayed	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
with	NULL
3-1	NULL
pre-B-cell	NULL
nuclear	NULL
extract	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
pmol	NULL
of	NULL
an	NULL
unlabeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
4E1	NULL
motif	NULL
.	NULL

Arrows	NULL
B	NULL
and	NULL
F	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
bound	NULL
and	NULL
free	NULL
DNA	NULL
probe	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
Left	NULL
)	NULL
Dimethyl	NULL
sulfate	NULL
(	NULL
DMS	NULL
)	NULL
methylation	NULL
interference	NULL
assay	NULL
.	NULL

Bound	NULL
(	NULL
B	NULL
)	NULL
,	NULL
free	NULL
(	NULL
F	NULL
)	NULL
,	NULL
and	NULL
A+G	NULL
sequencing	NULL
reaction	NULL
(	NULL
A+G	NULL
)	NULL
lanes	NULL
are	NULL
shown	NULL
.	NULL

Protein	NULL
contact	NULL
sites	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

(	NULL
Lower	NULL
Right	NULL
)	NULL
Summary	NULL
of	NULL
the	NULL
locations	NULL
of	NULL
these	NULL
residues	NULL
(	NULL
open	NULL
circles	NULL
)	NULL
.	NULL

DMS	NULL
methylation	NULL
interference	NULL
pattern	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
uE1	NULL
site	NULL
is	NULL
included	NULL
for	NULL
comparison	NULL
and	NULL
is	NULL
taken	NULL
from	NULL
Ephrussi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
20	NULL
)	NULL
and	NULL
Weinberger	NULL
et	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
.	NULL

includes	NULL
a	NULL
portion	NULL
with	NULL
11	NULL
consecutive	NULL
acid	NULL
residues	NULL
between	NULL
amino	NULL
acids	NULL
43	NULL
and	NULL
53	NULL
.	NULL

The	NULL
segment	NULL
between	NULL
residues	NULL
16	NULL
and	NULL
35	NULL
contains	NULL
sequences	NULL
consistent	NULL
with	NULL
the	NULL
ability	NULL
to	NULL
form	NULL
a	NULL
negatively	NULL
charged	NULL
amphipathic	NULL
a-helix	NULL
.	NULL

This	NULL
highly	NULL
acidic	NULL
N	NULL
terminus	NULL
is	NULL
reminiscent	NULL
of	NULL
transcriptional	NULL
activation	NULL
domains	NULL
found	NULL
in	NULL
other	NULL
transcriptional	NULL
regulators	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
the	NULL
segment	NULL
between	NULL
residues	NULL
70	NULL
and	NULL
80	NULL
is	NULL
unusual	NULL
in	NULL
that	NULL
it	NULL
consists	NULL
of	NULL
11	NULL
consecutive	NULL
histidines	NULL
.	NULL

The	NULL
transcriptional	NULL
repressor	NULL
Tst-1	NULL
(	NULL
SCIP	NULL
)	NULL
also	NULL
contains	NULL
regions	NULL
rich	NULL
in	NULL
histidine	NULL
as	NULL
well	NULL
as	NULL
a	NULL
stretch	NULL
of	NULL
6	NULL
consecutive	NULL
histidine	NULL
residues	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Fourth	NULL
,	NULL
the	NULL
region	NULL
between	NULL
amino	NULL
acids	NULL
154	NULL
and	NULL
198	NULL
is	NULL
very	NULL
rich	NULL
in	NULL
alanine	NULL
and	NULL
glycine	NULL
residues	NULL
(	NULL
26	NULL
of	NULL
45	NULL
;	NULL
58	NULL
%	NULL
)	NULL
.	NULL

This	NULL
region	NULL
also	NULL
includes	NULL
a	NULL
stretch	NULL
of	NULL
4	NULL
consecutive	NULL
serines	NULL
between	NULL
residues	NULL
164	NULL
and	NULL
167	NULL
.	NULL

The	NULL
repressor	NULL
Tst-1	NULL
(	NULL
SCIP	NULL
)	NULL
also	NULL
contains	NULL
extensive	NULL
regions	NULL
rich	NULL
in	NULL
alanine	NULL
and	NULL
glycine	NULL
(	NULL
45	NULL
%	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
putative	NULL
repressor	NULL
domain	NULL
in	NULL
the	NULL
transcriptional	NULL
repressor	NULL
Kruppel	NULL
is	NULL
rich	NULL
in	NULL
alanine	NULL
residues	NULL
(	NULL
27	NULL
)	NULL
.	NULL

A	NULL
search	NULL
of	NULL
the	NULL
National	NULL
Biomedical	NULL
Research	NULL
Foundation-Protein	NULL
Identification	NULL
Resource	NULL
(	NULL
release	NULL
26	NULL
)	NULL
data	NULL
base	NULL
revealed	NULL
homologies	NULL
to	NULL
numerous	NULL
transcription	NULL
factor	NULL
IIIA-type	NULL
finger	NULL
proteins	NULL
.	NULL

Particularly	NULL
striking	NULL
was	NULL
a	NULL
76	NULL
%	NULL
homol-ogy	NULL
in	NULL
the	NULL
zinc	NULL
finger	NULL
region	NULL
to	NULL
the	NULL
finger	NULL
protein	NULL
REX-1	NULL
(	NULL
28	NULL
)	NULL
.	NULL

No	NULL
data	NULL
base	NULL
homologies	NULL
to	NULL
other	NULL
segments	NULL
of	NULL
the	NULL
NF-E1l	NULL
sequence	NULL
were	NULL
observed	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
Geccac	NULL
eac	NULL
Cosa	NULL
accacasccsreaces	NULL
MOA	NULL
$	NULL
G	NULL
D	NULL
To	NULL
L	NULL
v	NULL
f	NULL
A	NULL
f	NULL
D	NULL
G	NULL
§	NULL
E	NULL
M	NULL
P	NULL
A	NULL
CGSAGCCCTCAGCC	NULL
ATG	NULL
GCC	NULL
TCG	NULL
@	NULL
@	NULL
C	NULL
GAC	NULL
ACC	NULL
CTC	NULL
TAC	NULL
ATC	NULL
GGC	NULL
ACG	NULL
GAC	NULL
GBC	NULL
TCG	NULL
GAG	NULL
ATG	NULL
CCG	NULL
E|vztgcsusvzrurvetusr~rv	NULL
Gas	NULL
ATC	NULL
GT	NULL
Gas	NULL
CTa	NULL
Cac	NULL
GaG	NULL
ATC	NULL
GAG	NULL
GTG	NULL
GAG	NULL
ACC	NULL
ATC	NULL
CCG	NULL
GTG	NULL
GAG	NULL
ACC	NULL
ATC	NULL
GAG	NULL
ACC	NULL
ACA	NULL
GTG	NULL
v_a	NULL
p	NULL
&	NULL
a	NULL
a	NULL
e_	NULL
a	NULL
o	NULL
9:6	NULL
e_	NULL
o	NULL
lin	NULL
dic	NULL
boc	NULL
in	NULL
Pc	NULL
tete	NULL
2	NULL
2	NULL
&	NULL
&	NULL
&	NULL
B	NULL
ote	NULL
cfc	NULL
ae	NULL
ak	NULL
A	NULL
L_	NULL
@	NULL
R	NULL
i	NULL
v	NULL
t	NULL
o	NULL
o	NULL
®	NULL
t	NULL
a	NULL
v	NULL
gagesanv	NULL
mmwmmmmmmmmmmgc	NULL
cas	NULL
cas	NULL
ate	NULL
atc	NULL
cre	NULL
ore	NULL
e	NULL
f	NULL
®	NULL
e	NULL
e	NULL
v	NULL
v	NULL
G	NULL
@	NULL
0	NULL
o	NULL
s	NULL
d	NULL
G	NULL
i	NULL
R	NULL
aA	NULL
E	NULL
D	NULL
a	NULL
F	NULL
f	NULL
Cas	NULL
ans	NULL
cac	NULL
Gas	NULL
aas	NULL
ate	NULL
aTe	NULL
agt	NULL
gag	NULL
aac	NULL
Gac	NULL
Tos	NULL
Gac	NULL
gag	NULL
CTG	NULL
Cac	NULL
get	NULL
gas	NULL
Gac	NULL
ggg	NULL
TTc	NULL
Gac	NULL
Do	NULL
@	NULL
l	NULL
k	NULL
d	NULL
P	NULL
v	NULL
P	NULL
A	NULL
P	NULL
A	NULL
G	NULL
G	NULL
b	NULL
D	NULL
D	NULL
y	NULL
i	NULL
E	NULL
a	NULL
T	NULL
i	NULL
GaT	NULL
CaG	NULL
ATT	NULL
CTC	NULL
ATC	NULL
CCG	NULL
GTS	NULL
CCC	NULL
ggg	NULL
COG	NULL
GGC	NULL
Gat	NULL
@	NULL
@	NULL
Gac	NULL
Gac	NULL
Gac	NULL
TAC	NULL
ATT	NULL
gaa	NULL
Cas	NULL
ACG	NULL
CTG	NULL
vo	NULL
T	NULL
v	NULL
A	NULL
A	NULL
A	NULL
G	NULL
K	NULL
$	NULL
G	NULL
G	NULL
G	NULL
G	NULL
§	NULL
s	NULL
8	NULL
s	NULL
G	NULL
G	NULL
G	NULL
R	NULL
v	NULL
are	NULL
aoc	NULL
ete	NULL
aos	NULL
aos	NULL
ace	NULL
gap	NULL
ans	NULL
asc	NULL
Sac	NULL
aar	NULL
aac	NULL
gap	NULL
Tos	NULL
Tos	NULL
Tos	NULL
TOG	NULL
Ga	NULL
gC	NULL
aac	NULL
Cac	NULL
orc	NULL
Ko	NULL
K	NULL
G	NULL
G	NULL
G	NULL
K	NULL
K	NULL
§	NULL
G	NULL
K	NULL
K	NULL
§	NULL
v	NULL
L	NULL
$	NULL
G	NULL
G	NULL
a	NULL
G	NULL
aA	NULL
A	NULL
G	NULL
aG	NULL
anc	NULL
aB	NULL
gag	NULL
ans	NULL
aas	NULL
AGC	NULL
ggC	NULL
¥	NULL
AAG	NULL
AGT	NULL
TaC	NULL
CTc	NULL
AGC	NULL
@	NULL
@	NULL
C	NULL
gag	NULL
ace	NULL
Gac	NULL
ace	NULL
G	NULL
G	NULL
G	NULL
A	NULL
D	NULL
P	NULL
G	NULL
w	NULL
k	NULL
K	NULL
w	NULL
E	NULL
Q	NULL
k	NULL
G	NULL
v	NULL
0	NULL
i	NULL
K	NULL
f	NULL
i	NULL
oE	NULL
GBC	NULL
aac	NULL
gar	NULL
acr	NULL
cac	NULL
cos	NULL
ge	NULL
C	NULL
AMG	NULL
AAG	NULL
Tas	NULL
GaG	NULL
CAG	NULL
AAG	NULL
CAG	NULL
GTG	NULL
CAG	NULL
ATC	NULL
AAG	NULL
ACC	NULL
CTG	NULL
GAG	NULL
G	NULL
E	NULL
F	NULL
s	NULL
vo	NULL
T	NULL
Mow	NULL
s	NULL
s	NULL
0	NULL
E	NULL
kK	NULL
K	NULL
b	NULL
g_	NULL
D	NULL
w	NULL
E	NULL
T	NULL
v	NULL
v	NULL
E	NULL
newm	NULL
:	NULL
mmmAmmmmmrwmwauﬂmcarmmmcnw	NULL
E0	NULL
0	NULL
}	NULL
)	NULL
i_	NULL
G	NULL
€	NULL
N	NULL
§	NULL
R	NULL
R	NULL
D	NULL
v	NULL
$	NULL
s	NULL
E	NULL
Y	NULL
Mot	NULL
g	NULL
K	NULL
k	NULL
L	NULL
R	NULL
p	NULL
GAA	NULL
CAG	NULL
ATC	NULL
ATT	NULL
GGA	NULL
GAG	NULL
AAC	NULL
TCA	NULL
CCT	NULL
CCT	NULL
GAT	NULL
TAT	NULL
TCA	NULL
GAA	NULL
TAT	NULL
ATG	NULL
ACA	NULL
@	NULL
@	NULL
a	NULL
AAG	NULL
AMA	NULL
CTT	NULL
CCT	NULL
CCT	NULL
@	NULL
a	NULL
)	NULL
1	NULL
R	NULL
G	NULL
1	NULL
0	NULL
L	NULL
8	NULL
Do	NULL
P	NULL
k	NULL
0	NULL
i	NULL
A	NULL
E	NULL
F	NULL
A_	NULL
A	NULL
Mok	NULL
P	NULL
aA	NULL
964	NULL
9B	NULL
»	NULL
ATA	NULL
CCT	NULL
gag	NULL
att	NULL
GAC	NULL
CTC	NULL
Toa	NULL
GAT	NULL
CCC	NULL
AAA	NULL
CAA	NULL
CTG	NULL
GCA	NULL
GAA	NULL
TT	NULL
?	NULL

get	NULL
AG	NULL
ATG	NULL
AAG	NULL
CCA	NULL
AGA	NULL
C_	NULL
f	NULL
k	NULL
M	NULL
F	NULL
A	NULL
A	NULL
R	NULL
A	NULL
t	NULL
u	NULL
Acvgxc	NULL
cor	NULL
Cit	NULL
ama	NULL
ggg	NULL
Tac	NULL
Aca	NULL
An	NULL
ATG	NULL
TTC	NULL
aG	NULL
K	NULL
l	NULL
K	NULL
E	NULL
D	NULL
D	NULL
AAA	NULL
ATT	NULL
AAA	NULL
GAA	NULL
GAT	NULL
GAT	NULL
CT	NULL
CCa	NULL
AGA	NULL
ACA	NULL
ATA	NULL
b	NULL
N	NULL
%	NULL
A	NULL
M	NULL
oR	NULL
K	NULL
L	NULL
T	NULL
GFRVQVCAECO	NULL
armmnummmgvmgcwcgcwcmm	NULL
atc	NULL
Tar	NULL
gca	NULL
aaa	NULL
tot	NULL
gnc	NULL
KoA	NULL
E	NULL
v	NULL
E	NULL
s	NULL
s	NULL
k	NULL
L	NULL
k	NULL
aA	NULL
0	NULL
i	NULL
v	NULL
T	NULL
e	NULL
«	NULL
e	NULL
k	NULL
e	NULL
r	NULL
:	NULL
o	NULL
mmmmmmmmcnwcmgcwmmgtmmmmmw	NULL
#	NULL
gu	NULL
ss	NULL
sn	NULL
si	NULL
#	NULL
4	NULL
§3	NULL
#	NULL
#	NULL
Ba	NULL
ta	NULL
O6	NULL
ga	NULL
He	NULL
8s	NULL
$	NULL
s	NULL
3	NULL
#	NULL
(	NULL
fae	NULL
Toa	NULL
Tro	NULL
Ea	NULL
Bag	NULL
Sor	NULL
Sag	NULL
San	NULL
Soc	NULL
rr	NULL
fea	NULL
ra	NULL
Sac	NULL
fro	NULL
thr	NULL
tra	NULL
che	NULL
sea	NULL
Sr	NULL
atacia	NULL
ate	NULL
&	NULL
|	NULL
ims	NULL
T	NULL
e	NULL
p	NULL
Rr	NULL
®	NULL
v	NULL
v	NULL
C	NULL
®	NULL
F	NULL
D	NULL
G	NULL
CoN	NULL
K	NULL
K	NULL
F	NULL
A	NULL
g	NULL
8s	NULL
T	NULL
u	NULL
.	NULL

Ld	NULL
mnwmcec'mmmwcmmvmmurmmmnwmmmm	NULL
we	NULL
tan	NULL
B	NULL
:	NULL
mio	NULL
ria	NULL
aia	NULL
B	NULL
alts	NULL
nto	NULL
dhs	NULL
a	NULL
dio	NULL
sto	NULL
e	NULL
-	NULL
(	NULL
#	NULL
1	NULL
CC	NULL
ATCT	NULL
m	NULL
TTGTATATTATT	NULL
TT	NULL
loud	NULL
TTAAAAATGA	NULL
ACCT	NULL
TGTTTTGATAAAGTAGTAAAAATTAA	NULL
TTACTA	NULL
1406	NULL
AGATGACATTGC	NULL
T	NULL
ICACAGTGTITTTGTAAAGTGTGGTC	NULL
1571	NULL
co	NULL
Ter	NULL
TC	NULL
1046	NULL
TTTTCACATTCT	NULL
TGOCTTACAATTTTTTTAATTTTGTATTY	NULL
1732	NULL
TGTACACTTTIT	NULL
TTT	NULL
TTGCTTGCAGTAG	NULL
1788	NULL
ATTTICTT	NULL
TT	NULL
GTTATATA	NULL
1673	NULL
TT	NULL
Ld	NULL
TTGAATCATGTAGTATCAAATATTAGATGTGATTTAATAGTGTTAATCAATTTAAACCCATTTTAGTGACTTTTTT	NULL
2008	NULL
TTTCCAAAAAAATACTGCCAGATGCTGATGT	NULL
TIC	NULL
TCAGT	NULL
mow	NULL
AGTTGTAGAATGTATTGTACC	NULL
TTTTAACACCTGAYGTGTACAYCOC	NULL
‘	NULL
TGTAACWWYE	NULL
2176	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

DNA	NULL
and	NULL
predicted	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
NF-E1l	NULL
.	NULL

Amino	NULL
acid	NULL
and	NULL
nucleotide	NULL
coordinates	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

Histidine	NULL
residues	NULL
are	NULL
circled	NULL
.	NULL

Alanine	NULL
and	NULL
glycine	NULL
residues	NULL
are	NULL
underlined	NULL
.	NULL

The	NULL
two	NULL
boxed	NULL
regions	NULL
denote	NULL
the	NULL
locations	NULL
of	NULL
the	NULL
11	NULL
consecutive	NULL
acid	NULL
residues	NULL
near	NULL
the	NULL
N	NULL
terminus	NULL
and	NULL
the	NULL
zinc	NULL
finger	NULL
region	NULL
at	NULL
the	NULL
C	NULL
terminus	NULL
.	NULL

Asterisk	NULL
shows	NULL
the	NULL
location	NULL
of	NULL
the	NULL
termination	NULL
codon	NULL
.	NULL

The	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
untranslated	NULL
sequences	NULL
are	NULL
shown	NULL
in	NULL
italics	NULL
.	NULL

The	NULL
two	NULL
underlined	NULL
sequences	NULL
in	NULL
the	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
indicate	NULL
potential	NULL
polyadenylylation	NULL
signals	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
clones	NULL
131	NULL
and	NULL
324	NULL
were	NULL
compared	NULL
over	NULL
=800	NULL
bp	NULL
.	NULL

Both	NULL
sequences	NULL
were	NULL
identical	NULL
except	NULL
at	NULL
two	NULL
locations	NULL
.	NULL

At	NULL
nucleotide	NULL
position	NULL
268	NULL
,	NULL
a	NULL
G	NULL
to	NULL
A	NULL
transition	NULL
results	NULL
in	NULL
an	NULL
arginine	NULL
to	NULL
histidine	NULL
change	NULL
in	NULL
clone	NULL
324	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
CCA	NULL
codon	NULL
is	NULL
deleted	NULL
in	NULL
clone	NULL
324	NULL
between	NULL
nucleotide	NULL
positions	NULL
271	NULL
and	NULL
273	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
loss	NULL
of	NULL
a	NULL
single	NULL
histidine	NULL
residue	NULL
.	NULL

These	NULL
differences	NULL
presumably	NULL
reflect	NULL
polymorphisms	NULL
of	NULL
the	NULL
same	NULL
gene	NULL
.	NULL

DNA	NULL
Binding	NULL
Characterization	NULL
of	NULL
the	NULL
Cloned	NULL
and	NULL
Endogenous	NULL
NF-E1	NULL
Proteins	NULL
.	NULL

Clone	NULL
131	NULL
was	NULL
transcribed	NULL
and	NULL
translated	NULL
in	NULL
vitro	NULL
and	NULL
the	NULL
synthesized	NULL
protein	NULL
was	NULL
assayed	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
NF-E1	NULL
DNA	NULL
probe	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
synthesized	NULL
protein	NULL
bound	NULL
to	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
NF-E1	NULL
probe	NULL
and	NULL
migrated	NULL
with	NULL
a	NULL
mobility	NULL
identical	NULL
to	NULL
the	NULL
endogenous	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

The	NULL
protein-DNA	NULL
complex	NULL
was	NULL
abolished	NULL
by	NULL
competition	NULL
with	NULL
unlabeled	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
NF-E1	NULL
or	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
1E1	NULL
binding	NULL
sites	NULL
,	NULL
but	NULL
not	NULL
with	NULL
one	NULL
containing	NULL
a	NULL
mutant	NULL
NF-E1	NULL
sequence	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
.	NULL

The	NULL
zinc	NULL
chelator	NULL
1,10-phenanthroline	NULL
(	NULL
29	NULL
)	NULL
abolished	NULL
DNA	NULL
binding	NULL
by	NULL
the	NULL
in	NULL
vitro	NULL
synthesized	NULL
and	NULL
the	NULL
endogenous	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lane	NULL
7	NULL
;	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Biochemistry	NULL
:	NULL
Park	NULL
and	NULL
Atchison	NULL
A	NULL
=_	NULL
B	NULL
0	NULL
f	NULL
In	NULL
Vitro	NULL
131	NULL
w	NULL
re	NULL
13	NULL
Nuclear	NULL
Extract	NULL
BS	NULL
5	NULL
$	NULL
5	NULL
CC	NULL
]	NULL
S	NULL
ce	NULL
:	NULL
S	NULL
2	NULL
®	NULL
E	NULL
§	NULL
F1	NULL
H	NULL
m	NULL
&	NULL
Fr	NULL
g	NULL
5	NULL
Competitor	NULL
:	NULL
0	NULL
0	NULL
0	NULL
¥	NULL
¥	NULL
4	NULL
n	NULL
o	NULL
«	NULL
¥	NULL
i	NULL
>	NULL
Bbe	NULL
ao	NULL
a\	NULL
0	NULL
N	NULL
*	NULL
tut	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

DNA	NULL
binding	NULL
characteristics	NULL
of	NULL
the	NULL
cloned	NULL
and	NULL
endogenous	NULL
protein	NULL
.	NULL

Above	NULL
each	NULL
lane	NULL
the	NULL
source	NULL
of	NULL
each	NULL
protein	NULL
is	NULL
indicated	NULL
(	NULL
in	NULL
vitro	NULL
translated	NULL
clone	NULL
131	NULL
or	NULL
3-1	NULL
nuclear	NULL
extract	NULL
)	NULL
,	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
oligonucleotide	NULL
competitors	NULL
is	NULL
indicated	NULL
(	NULL
100	NULL
ng	NULL
)	NULL
,	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
zinc	NULL
chelator	NULL
1,10-phenanthroline	NULL
is	NULL
indicated	NULL
.	NULL

wt	NULL
,	NULL
Wild	NULL
type	NULL
;	NULL
mut	NULL
,	NULL
mutant	NULL
.	NULL

Arrows	NULL
B	NULL
and	NULL
F	NULL
indicate	NULL
the	NULL
locations	NULL
of	NULL
the	NULL
bound	NULL
and	NULL
free	NULL
DNA	NULL
probe	NULL
,	NULL
respectively	NULL
.	NULL

Inclusion	NULL
of	NULL
the	NULL
zinc	NULL
chelator	NULL
in	NULL
a	NULL
binding	NULL
assay	NULL
with	NULL
a	NULL
non-zinc	NULL
finger	NULL
protein	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

NF-E1	NULL
Is	NULL
a	NULL
Candidate	NULL
Repressor	NULL
Protein	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
NF-El	NULL
contains	NULL
regions	NULL
similar	NULL
to	NULL
transcriptional	NULL
activators	NULL
(	NULL
acid	NULL
rich	NULL
)	NULL
as	NULL
well	NULL
as	NULL
to	NULL
transcriptional	NULL
repressors	NULL
(	NULL
Ala+Gly-rich	NULL
and	NULL
His-rich	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
set	NULL
out	NULL
to	NULL
determine	NULL
whether	NULL
NF-E1	NULL
would	NULL
exert	NULL
a	NULL
positive	NULL
or	NULL
a	NULL
negative	NULL
influence	NULL
on	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
a	NULL
synthetic	NULL
promoter	NULL
.	NULL

NF-E1	NULL
was	NULL
expressed	NULL
as	NULL
a	NULL
fusion	NULL
protein	NULL
with	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
GAL4	NULL
1-147	NULL
)	NULL
and	NULL
cotransfected	NULL
with	NULL
a	NULL
TKCAT	NULL
plasmid	NULL
containing	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
GAL4-TKCAT	NULL
plasmid	NULL
exhibited	NULL
readily	NULL
detectable	NULL
levels	NULL
of	NULL
basal	NULL
expression	NULL
in	NULL
3T3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Cotransfection	NULL
with	NULL
the	NULL
GAL4-E1	NULL
fusion	NULL
plasmid	NULL
repressed	NULL
CAT	NULL
levels	NULL
10-fold	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
while	NULL
plasmids	NULL
that	NULL
contained	NULL
the	NULL
NF-E1l	NULL
sequences	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
9807	NULL
in	NULL
the	NULL
opposite	NULL
orientation	NULL
(	NULL
GAL4-rE1	NULL
)	NULL
or	NULL
the	NULL
GALA	NULL
1-147	NULL
sequences	NULL
alone	NULL
(	NULL
GAL4	NULL
1-147	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
expression	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
above	NULL
repression	NULL
could	NULL
be	NULL
due	NULL
to	NULL
NF-E1l	NULL
directly	NULL
repressing	NULL
promoter	NULL
activity	NULL
.	NULL

Alternatively	NULL
,	NULL
NF-E1	NULL
could	NULL
be	NULL
titrating	NULL
factors	NULL
necessary	NULL
for	NULL
promoter	NULL
activity	NULL
(	NULL
squelching	NULL
)	NULL
.	NULL

To	NULL
distinguish	NULL
between	NULL
these	NULL
possibilities	NULL
,	NULL
we	NULL
cotransfected	NULL
the	NULL
various	NULL
effector	NULL
constructs	NULL
with	NULL
a	NULL
reporter	NULL
plasmid	NULL
that	NULL
lacked	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
site	NULL
(	NULL
TKCAT	NULL
)	NULL
.	NULL

TKCAT	NULL
expression	NULL
was	NULL
unaffected	NULL
by	NULL
cotransfection	NULL
with	NULL
the	NULL
GAL4-E1	NULL
construct	NULL
,	NULL
indicating	NULL
that	NULL
DNA	NULL
binding	NULL
is	NULL
necessary	NULL
for	NULL
the	NULL
repressive	NULL
activity	NULL
of	NULL
NF-E1	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
5-8	NULL
)	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
the	NULL
repression	NULL
observed	NULL
above	NULL
was	NULL
not	NULL
due	NULL
to	NULL
an	NULL
unusual	NULL
feature	NULL
of	NULL
the	NULL
GAL4-E1	NULL
chimera	NULL
,	NULL
we	NULL
expressed	NULL
the	NULL
native	NULL
NF-El	NULL
cDNA	NULL
without	NULL
GAL4	NULL
sequences	NULL
.	NULL

The	NULL
NF-E1	NULL
expression	NULL
plasmid	NULL
(	NULL
SV-E1	NULL
)	NULL
repressed	NULL
activity	NULL
of	NULL
a	NULL
TKCAT	NULL
reporter	NULL
containing	NULL
the	NULL
NF-El	NULL
binding	NULL
site	NULL
,	NULL
(	NULL
E1	NULL
)	NULL
,	NULL
TKCAT	NULL
,	NULL
while	NULL
an	NULL
expression	NULL
plasmid	NULL
with	NULL
the	NULL
NF-E1	NULL
sequence	NULL
in	NULL
the	NULL
opposite	NULL
orientation	NULL
(	NULL
SV-rE1	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
lanes	NULL
9-11	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
functional	NULL
role	NULL
of	NULL
the	NULL
NF-E1	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
intact	NULL
«	NULL
E3	NULL
'	NULL
enhancer	NULL
,	NULL
we	NULL
prepared	NULL
a	NULL
linker	NULL
scan	NULL
mutation	NULL
of	NULL
the	NULL
NF-E1	NULL
binding	NULL
site	NULL
.	NULL

This	NULL
construct	NULL
gave	NULL
a	NULL
small	NULL
,	NULL
but	NULL
reproducible	NULL
,	NULL
1.3-fold	NULL
activation	NULL
of	NULL
the	NULL
intact	NULL
«	NULL
E3	NULL
'	NULL
enhancer	NULL
in	NULL
pre-B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
4	NULL
,	NULL
construct	NULL
J	NULL
)	NULL
.	NULL

This	NULL
low	NULL
level	NULL
of	NULL
activation	NULL
was	NULL
not	NULL
unexpected	NULL
given	NULL
our	NULL
evidence	NULL
that	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
enhancer	NULL
contains	NULL
multiple	NULL
negative	NULL
elements	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
NF-E1l	NULL
site	NULL
playing	NULL
a	NULL
negative	NULL
role	NULL
in	NULL
«	NULL
E3	NULL
'	NULL
enhancer	NULL
activity	NULL
rather	NULL
than	NULL
a	NULL
positive	NULL
role	NULL
.	NULL

DISCUSSION	NULL
We	NULL
have	NULL
determined	NULL
that	NULL
while	NULL
the	NULL
intact	NULL
«	NULL
E3	NULL
'	NULL
enhancer	NULL
is	NULL
silent	NULL
at	NULL
the	NULL
pre-B-cell	NULL
stage	NULL
,	NULL
the	NULL
132-bp	NULL
core	NULL
segment	NULL
is	NULL
active	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
a	NULL
region	NULL
downstream	NULL
of	NULL
the	NULL
enhancer	NULL
core	NULL
that	NULL
contains	NULL
sequences	NULL
that	NULL
repress	NULL
enhancer	NULL
activity	NULL
in	NULL
a	NULL
position-	NULL
and	NULL
orientation-independent	NULL
manner	NULL
at	NULL
the	NULL
pre-B-cell	NULL
stage	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
a	NULL
nuclear	NULL
factor	NULL
,	NULL
NF-E1	NULL
,	NULL
that	NULL
binds	NULL
to	NULL
a	NULL
DNA	NULL
sequence	NULL
motif	NULL
within	NULL
this	NULL
negative-acting	NULL
segment	NULL
and	NULL
have	NULL
isolated	NULL
cDNA	NULL
clones	NULL
encoding	NULL
this	NULL
protein	NULL
.	NULL

NF-E1	NULL
also	NULL
binds	NULL
to	NULL
the	NULL
uE1	NULL
site	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
enhancer	NULL
.	NULL

In	NULL
previous	NULL
studies	NULL
,	NULL
mutation	NULL
or	NULL
deletion	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
uE1	NULL
site	NULL
gave	NULL
ambiguous	NULL
results	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
,	NULL
uE1	NULL
site	NULL
mutation	NULL
led	NULL
to	NULL
a	NULL
decrease	NULL
in	NULL
immunoglobulin	NULL
heavy-chain	NULL
enhancer	NULL
activity	NULL
in	NULL
plasmacytoma	NULL
cells	NULL
(	NULL
10	NULL
,	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

In	NULL
another	NULL
case	NULL
,	NULL
no	NULL
effect	NULL
on	NULL
enhancer	NULL
activity	NULL
was	NULL
observed	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
Reporter	NULL
:	NULL
(	NULL
GAL4	NULL
)	NULL
sTKCAT	NULL
TKCAT	NULL
(	NULL
E1	NULL
)	NULL
4TKCAT	NULL
I	NULL
I	NULL
4	NULL
y	NULL
_	NULL
I	NULL
ty	NULL
_	NULL
|	NULL
I	NULL
T	NULL
r	NULL
T	NULL
G	NULL
w	NULL
``	NULL
rrr	NULL
ari	NULL
8	NULL
-	NULL
30	NULL
30	NULL
]	NULL
0	NULL
0	NULL
l	NULL
i	NULL
i	NULL
0	NULL
Ca	NULL
i	NULL
a	NULL
-	NULL
G	NULL
-	NULL
$	NULL
3	NULL
a	NULL
-	NULL
0	NULL
fu	NULL
5	NULL
cA	NULL
a	NULL
n	NULL
<	NULL
a	NULL
«	NULL
i	NULL
>	NULL
DC	NULL
o	NULL
a	NULL
00.0.	NULL
o	NULL
o	NULL
®	NULL
®	NULL
®	NULL
s	NULL
``	NULL
%	NULL
a	NULL
#	NULL
m	NULL
2	NULL
,	NULL
#	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

NF-E1	NULL
represses	NULL
basal	NULL
promoter	NULL
activity	NULL
.	NULL

Above	NULL
each	NULL
lane	NULL
the	NULL
reporter	NULL
and	NULL
the	NULL
cotransfected	NULL
effector	NULL
plasmid	NULL
are	NULL
indicated	NULL
.	NULL

9808	NULL
Biochemistry	NULL
:	NULL
Park	NULL
and	NULL
Atchison	NULL
mutation	NULL
of	NULL
the	NULL
E1	NULL
site	NULL
led	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
immunoglobulin	NULL
heavy-chain	NULL
enhancer	NULL
activity	NULL
in	NULL
L	NULL
cells	NULL
,	NULL
suggesting	NULL
a	NULL
repressive	NULL
role	NULL
in	NULL
tissue	NULL
specificity	NULL
(	NULL
32	NULL
)	NULL
.	NULL

NF-E1	NULL
also	NULL
appears	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
c-myc	NULL
promoter	NULL
(	NULL
33	NULL
)	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
NF-E1	NULL
(	NULL
common	NULL
factor	NULL
1	NULL
;	NULL
CF-1	NULL
)	NULL
binds	NULL
to	NULL
a	NULL
sequence	NULL
with	NULL
positive-acting	NULL
properties	NULL
.	NULL

In	NULL
the	NULL
context	NULL
of	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
enhancer	NULL
,	NULL
we	NULL
found	NULL
that	NULL
NF-El	NULL
binds	NULL
to	NULL
a	NULL
DNA	NULL
segment	NULL
with	NULL
negative-acting	NULL
properties	NULL
in	NULL
pre-B	NULL
cells	NULL
.	NULL

Cotransfection	NULL
of	NULL
NF-E1	NULL
expression	NULL
plasmids	NULL
with	NULL
various	NULL
reporter	NULL
constructs	NULL
resulted	NULL
in	NULL
repressed	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
our	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
NF-E1	NULL
being	NULL
a	NULL
transcriptional	NULL
repressor	NULL
.	NULL

Somewhat	NULL
surprisingly	NULL
,	NULL
NF-E1	NULL
binding	NULL
activity	NULL
is	NULL
present	NULL
at	NULL
stages	NULL
of	NULL
B-cell	NULL
development	NULL
when	NULL
the	NULL
«	NULL
E3	NULL
'	NULL
enhancer	NULL
is	NULL
active	NULL
.	NULL

The	NULL
reason	NULL
for	NULL
its	NULL
lack	NULL
of	NULL
repression	NULL
at	NULL
the	NULL
B-cell	NULL
and	NULL
plasma	NULL
cell	NULL
stages	NULL
is	NULL
unclear	NULL
.	NULL

Possibly	NULL
at	NULL
these	NULL
stages	NULL
the	NULL
positive-acting	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
enhancer	NULL
are	NULL
sufficient	NULL
to	NULL
override	NULL
the	NULL
negative	NULL
influence	NULL
of	NULL
NF-E1	NULL
.	NULL

Alternatively	NULL
,	NULL
two	NULL
different	NULL
factors	NULL
might	NULL
bind	NULL
to	NULL
the	NULL
NF-E1	NULL
site	NULL
:	NULL
one	NULL
that	NULL
is	NULL
an	NULL
activator	NULL
and	NULL
one	NULL
that	NULL
is	NULL
a	NULL
repressor	NULL
.	NULL

Finally	NULL
,	NULL
NF-E1	NULL
might	NULL
act	NULL
as	NULL
both	NULL
a	NULL
repressor	NULL
and	NULL
an	NULL
activator	NULL
whose	NULL
activity	NULL
can	NULL
be	NULL
controlled	NULL
posttranslationally	NULL
.	NULL

At	NULL
the	NULL
completion	NULL
of	NULL
our	NULL
work	NULL
,	NULL
we	NULL
learned	NULL
that	NULL
NF-E1	NULL
was	NULL
independently	NULL
cloned	NULL
by	NULL
the	NULL
Shenk	NULL
laboratory	NULL
(	NULL
and	NULL
named	NULL
YY-1	NULL
)	NULL
based	NULL
on	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
adeno-associated	NULL
virus	NULL
P5	NULL
promoter	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
our	NULL
results	NULL
,	NULL
the	NULL
cloned	NULL
YY-1	NULL
protein	NULL
can	NULL
suppress	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
YY-1	NULL
binding	NULL
site	NULL
.	NULL

However	NULL
,	NULL
YY-1	NULL
also	NULL
appears	NULL
to	NULL
work	NULL
in	NULL
a	NULL
positive	NULL
sense	NULL
because	NULL
it	NULL
can	NULL
mediate	NULL
ElA	NULL
activation	NULL
of	NULL
the	NULL
P5	NULL
promoter	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Remarkably	NULL
,	NULL
the	NULL
mouse	NULL
equivalent	NULL
of	NULL
NF-E1	NULL
was	NULL
also	NULL
independently	NULL
cloned	NULL
by	NULL
the	NULL
Perry	NULL
laboratory	NULL
based	NULL
on	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
ribosomal	NULL
protein	NULL
promoters	NULL
(	NULL
36	NULL
)	NULL
.	NULL

NF-6	NULL
is	NULL
highly	NULL
homologous	NULL
(	NULL
>	NULL
98	NULL
%	NULL
)	NULL
to	NULL
the	NULL
human	NULL
NF-E1	NULL
.	NULL

Over	NULL
414	NULL
amino	NULL
acids	NULL
of	NULL
each	NULL
protein	NULL
,	NULL
there	NULL
are	NULL
only	NULL
7	NULL
amino	NULL
acid	NULL
differences	NULL
.	NULL

NF-6	NULL
is	NULL
unusual	NULL
in	NULL
that	NULL
it	NULL
binds	NULL
to	NULL
the	NULL
ribosomal	NULL
protein	NULL
promoters	NULL
at	NULL
a	NULL
location	NULL
downstream	NULL
of	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
.	NULL

NF-8	NULL
is	NULL
very	NULL
important	NULL
for	NULL
ribosomal	NULL
protein	NULL
promoter	NULL
function	NULL
because	NULL
mutation	NULL
of	NULL
its	NULL
DNA	NULL
binding	NULL
site	NULL
significantly	NULL
lowers	NULL
promoter	NULL
activity	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
NF-8	NULL
works	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
ribosomal	NULL
protein	NULL
promoters	NULL
.	NULL

Whether	NULL
NF-E1	NULL
is	NULL
a	NULL
bifunc-tional	NULL
protein	NULL
and	NULL
is	NULL
capable	NULL
of	NULL
functioning	NULL
as	NULL
an	NULL
activator	NULL
in	NULL
some	NULL
transcriptional	NULL
control	NULL
elements	NULL
,	NULL
and	NULL
a	NULL
repressor	NULL
in	NULL
others	NULL
,	NULL
will	NULL
require	NULL
more	NULL
detailed	NULL
analyses	NULL
.	NULL

We	NULL
thank	NULL
T.	NULL
Kadesch	NULL
for	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
enhancer	NULL
motifs	NULL
and	NULL
the	NULL
GAL4	NULL
1-147	NULL
plasmid	NULL
,	NULL
K.	NULL
Satymoorthy	NULL
for	NULL
1,10-phenanthroline	NULL
,	NULL
Y.	NULL
Shi	NULL
for	NULL
the	NULL
GAL4	NULL
TKCAT	NULL
plasmid	NULL
,	NULL
Y.	NULL
Kim	NULL
and	NULL
P.	NULL
Henthorn	NULL
for	NULL
computer	NULL
analysis	NULL
of	NULL
the	NULL
protein	NULL
sequence	NULL
,	NULL
and	NULL
N.	NULL
Avadhani	NULL
for	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
R.	NULL
Perry	NULL
and	NULL
T.	NULL
Shenk	NULL
for	NULL
sharing	NULL
results	NULL
prior	NULL
to	NULL
publication	NULL
.	NULL

K.P	NULL
.	NULL

is	NULL
grateful	NULL
to	NULL
In-Ho	NULL
Choi	NULL
for	NULL
constant	NULL
moral	NULL
support	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
RO1	NULL
GM42415	NULL
and	NULL
in	NULL
part	NULL
by	NULL
the	NULL
Lucille	NULL
P.	NULL
Markey	NULL
Charitable	NULL
Trust	NULL
and	NULL
the	NULL
Jessie	NULL
B.	NULL
Cox	NULL
Charitable	NULL
Trust	NULL
.	NULL

K.P	NULL
.	NULL

was	NULL
partially	NULL
supported	NULL
by	NULL
a	NULL
University	NULL
of	NULL
Pennsylvania	NULL
predoctoral	NULL
fellowship	NULL
in	NULL
the	NULL
Molecular	NULL
Biology	NULL
Graduate	NULL
Group	NULL
.	NULL

1	NULL
.	NULL

Queen	NULL
,	NULL
C.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1983	NULL
)	NULL
Cell	NULL
33	NULL
,	NULL
741-748	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Picard	NULL
,	NULL
D.	NULL
&	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1984	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
307	NULL
,	NULL
80-82	NULL
.	NULL

#	NULL
o	NULL
in	NULL
26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

&	NULL
io	NULL
go	NULL
~	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
Meyer	NULL
,	NULL
K.	NULL
B	NULL
.	NULL

&	NULL
Neuberger	NULL
,	NULL
M.	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
1959-1964	NULL
.	NULL

Meyer	NULL
,	NULL
K.	NULL
B.	NULL
,	NULL
Sharpe	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Surani	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

&	NULL
Neuberger	NULL
,	NULL
M.	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18	NULL
,	NULL
5609-5615	NULL
.	NULL

Stafford	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Queen	NULL
,	NULL
C.	NULL
(	NULL
1983	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
306	NULL
,	NULL
77-79	NULL
.	NULL

Pongubala	NULL
,	NULL
J.	NULL
M.	NULL
R.	NULL
&	NULL
Atchison	NULL
,	NULL
M.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
1040-1047	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
705-716	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
47	NULL
,	NULL
921-928	NULL
.	NULL

Atchison	NULL
,	NULL
M.	NULL
L.	NULL
&	NULL
Perry	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
48	NULL
,	NULL
121-128	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
,	NULL
Pierce	NULL
,	NULL
J.	NULL
W.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
236	NULL
,	NULL
1573-1577	NULL
.	NULL

Hagman	NULL
,	NULL
J.	NULL
,	NULL
Rudin	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Haasch	NULL
,	NULL
D.	NULL
,	NULL
Chaplin	NULL
,	NULL
D.	NULL
&	NULL
Storb	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
978-992	NULL
.	NULL

Zaret	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Liu	NULL
,	NULL
J.-K.	NULL
&	NULL
DiPersio	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
5469-5473	NULL
.	NULL

Sadowski	NULL
,	NULL
I.	NULL
,	NULL
Ma	NULL
,	NULL
J.	NULL
,	NULL
Triezenberg	NULL
,	NULL
S.	NULL
&	NULL
Ptashne	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
335	NULL
,	NULL
563-564	NULL
.	NULL

Graham	NULL
,	NULL
F.	NULL
L.	NULL
&	NULL
Van	NULL
der	NULL
Eb	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1973	NULL
)	NULL
Virology	NULL
52	NULL
,	NULL
456-467	NULL
.	NULL

Hall	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
Jacob	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
Ringold	NULL
,	NULL
G.	NULL
M.	NULL
&	NULL
Lee	NULL
,	NULL
F.	NULL
(	NULL
1983	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Appl	NULL
.	NULL

Genet	NULL
.	NULL

2	NULL
,	NULL
101-110	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Moffat	NULL
,	NULL
L.	NULL
F.	NULL
&	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044-1051	NULL
.	NULL

Singh	NULL
,	NULL
H.	NULL
,	NULL
Sen	NULL
,	NULL
R.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
&	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
319	NULL
,	NULL
154-158	NULL
.	NULL

Atchison	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Delmas	NULL
,	NULL
V.	NULL
&	NULL
Perry	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
3109-3117	NULL
.	NULL

Vinson	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
LaMarco	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Johnson	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
Landschulz	NULL
,	NULL
W.	NULL
H.	NULL
&	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1988	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
801-806	NULL
.	NULL

Ephrussi	NULL
,	NULL
A.	NULL
,	NULL
Church	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Tonegawa	NULL
,	NULL
S.	NULL
&	NULL
Gilbert	NULL
,	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
227	NULL
,	NULL
134-140	NULL
.	NULL

Weinberger	NULL
,	NULL
J.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
&	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
322	NULL
,	NULL
846-848	NULL
.	NULL

Kozak	NULL
,	NULL
M.	NULL
(	NULL
1984	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

12	NULL
,	NULL
857-872	NULL
.	NULL

Ptashne	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
335	NULL
,	NULL
683-689	NULL
.	NULL

Mitchell	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
245	NULL
,	NULL
371-378	NULL
.	NULL

He	NULL
,	NULL
X.	NULL
,	NULL
Gerrero	NULL
,	NULL
R.	NULL
,	NULL
Simmons	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Park	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Lin	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Swanson	NULL
,	NULL
L.	NULL
W.	NULL
&	NULL
Rosenfeld	NULL
,	NULL
M.	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
1739-1744	NULL
.	NULL

Monuki	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Kuhn	NULL
,	NULL
R.	NULL
,	NULL
Weinmaster	NULL
,	NULL
G.	NULL
,	NULL
Trapp	NULL
,	NULL
B.	NULL
D.	NULL
&	NULL
Lemke	NULL
,	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
249	NULL
,	NULL
1300-1303	NULL
.	NULL

Licht	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Grossel	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Figge	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Hansen	NULL
,	NULL
U.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
346	NULL
,	NULL
76-79	NULL
.	NULL

Hosler	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
LaRosa	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
Grippo	NULL
,	NULL
J.	NULL
F.	NULL
&	NULL
Gudas	NULL
,	NULL
L.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
5623-5629	NULL
.	NULL

Sabbah	NULL
,	NULL
M.	NULL
,	NULL
Redeuith	NULL
,	NULL
G.	NULL
,	NULL
Secco	NULL
,	NULL
C.	NULL
&	NULL
Baulieu	NULL
,	NULL
E.-E.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262	NULL
,	NULL
8631-8635	NULL
.	NULL

Tsao	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
Wang	NULL
,	NULL
X.-F.	NULL
,	NULL
Peterson	NULL
,	NULL
C.	NULL
&	NULL
Calame	NULL
,	NULL
K.	NULL
(	NULL
1988	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16	NULL
,	NULL
3239-3253	NULL
.	NULL

Perez-Mutal	NULL
,	NULL
J.	NULL
,	NULL
Macchi	NULL
,	NULL
M.	NULL
&	NULL
Wasylyk	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16	NULL
,	NULL
6085-6096	NULL
.	NULL

Kiledjian	NULL
,	NULL
M.	NULL
,	NULL
Su	NULL
,	NULL
L.-K.	NULL
&	NULL
Kadesch	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
145-152	NULL
.	NULL

Riggs	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Merrell	NULL
,	NULL
K.	NULL
T.	NULL
,	NULL
Wilson	NULL
,	NULL
G.	NULL
&	NULL
Calame	NULL
,	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
1765-1769	NULL
.	NULL

Shi	NULL
,	NULL
Y.	NULL
,	NULL
Seto	NULL
,	NULL
E.	NULL
,	NULL
Chang	NULL
,	NULL
L.-S.	NULL
&	NULL
Shenk	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
67	NULL
,	NULL
377-388	NULL
.	NULL

Chang	NULL
,	NULL
L.-S.	NULL
,	NULL
Shi	NULL
,	NULL
Y	NULL
.	NULL

&	NULL
Shenk	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

63	NULL
,	NULL
3479-3488	NULL
.	NULL

Hariharan	NULL
,	NULL
N.	NULL
,	NULL
Kelley	NULL
,	NULL
D.	NULL
E.	NULL
&	NULL
Perry	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
9799-9803	NULL
.	NULL

Hariharan	NULL
,	NULL
N.	NULL
,	NULL
Kelley	NULL
,	NULL
D.	NULL
E.	NULL
&	NULL
Perry	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
1789-1800	NULL
.	NULL

